Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS

Nature Neuroscience

Volumn 18, Issue 8, 2015, Pages 1175-1182

  Prudencio, Mercedes ^a   Belzil, Veronique V ^a   Batra, Ranjan ^a   Ross, Christian A ^b   Gendron, Tania F ^a   Pregent, Luc J ^a   Murray, Melissa E ^a   Overstreet, Karen K ^c   Piazza Johnston, Amelia E ^c   Desaro, Pamela ^c   Bieniek, Kevin F ^a,b   DeTure, Michael ^a   Lee, Wing C ^a   Biendarra, Sherri M ^a   Davis, Mary D ^a   Baker, Matthew C ^a   Perkerson, Ralph B ^a   Van Blitterswijk, Marka ^a   Stetler, Caroline T ^a   Rademakers, Rosa ^a   Link, Christopher D ^d   Dickson, Dennis W ^a   Boylan, Kevin B ^c   Li, Hu ^a   Petrucelli, Leonard ^a   more..

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; RNA BINDING PROTEIN EWS; RNA POLYMERASE II; TRANSCRIPTOME; C9ORF72 PROTEIN, HUMAN; PROTEIN; RNA;

ADULT; ALTERNATIVE POLYADENYLATION; ALTERNATIVE RNA SPLICING; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIOACCUMULATION; BRAIN TISSUE; CEREBELLUM; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; EXON; FRONTAL CORTEX; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIDDLE AGED; MOTONEURON; NEXT GENERATION SEQUENCING; POLYADENYLATION; PRIORITY JOURNAL; RNA PROCESSING; SIGNAL TRANSDUCTION; AGED; COMPARATIVE STUDY; FRONTAL LOBE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SEQUENCE ANALYSIS;

ADULT; AGED; ALTERNATIVE SPLICING; AMYOTROPHIC LATERAL SCLEROSIS; CEREBELLUM; FRONTAL LOBE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP F-H; HUMANS; MIDDLE AGED; POLYADENYLATION; PROTEINS; RNA; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 84938421758     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.4065     Document Type: Article

References (68)

1. Geser, F. et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch. Neurol. 65, 636-641 (2008).
2. DeJesus-Hernandez, M. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245-256 (2011).
3. Renton, A.E. et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257-268 (2011).
4. van Blitterswijk, M., DeJesus-Hernandez, M. & Rademakers, R. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? Curr. Opin. Neurol. 25, 689-700 (2012).
5. Ash, P.E. et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specifc to c9FTD/ALS. Neuron 77, 639-646 (2013).
6. Mori, K. et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 126, 881-893 (2013).
7. Mori, K. et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 339, 1335-1338 (2013).
8. Gendron, T.F. et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 126, 829-844 (2013).
9. Mizielinska, S. et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science 345, 1192-1194 (2014).
10. May, S. et al. C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathol. 128, 485-503 (2014).
11. Zhang, Y.J. et al. Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol. 128, 505-524 (2014).
12. Kwon, I. et al. Poly-dipeptides encoded by the C9ORF72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science 345, 1139-1145 (2014).
13. Yamakawa, M. et al. Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS. Hum. Mol. Genet. 24, 1630-1645 (2015).
14. Wen, X. et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron 84, 1213-1225 (2014).
15. Tao, Z. et al. Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity. Hum. Mol. Genet. 24, 2426-2441 (2015).
16. Donnelly, C.J. et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80, 415-428 (2013).
17. Lagier-Tourenne, C. et al. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc. Natl. Acad. Sci. U.S.A. 110, E4530-E4539 (2013).
18. Sareen, D. et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl. Med. 5, 208ra149 (2013).
19. Lee, Y.B. et al. Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep. 5, 1178-1186 (2013).
20. Cooper-Knock, J. et al. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain 137, 2040-2051 (2014).
21. Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133 (2006).
22. Gendron, T.F., Josephs, K.A. & Petrucelli, L. Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration. Neuropathol. Appl. Neurobiol. 36, 97-112 (2010).
23. Sreedharan, J. et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672 (2008).
24. Kwiatkowski, T.J. Jr. et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208 (2009).
25. Vance, C. et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211 (2009).
26. Elden, A.C. et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466, 1069-1075 (2010).
27. Couthouis, J. et al. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 21, 2899-2911 (2012).
28. Ticozzi, N. et al. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156B, 285-290 (2011).
29. Kim, H.J. et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495, 467-473 (2013).
30. Wu, J., Anczukow, O., Krainer, A.R., Zhang, M.Q. & Zhang, C. OLego: fast and sensitive mapping of spliced mRNA-Seq reads using small seeds. Nucleic Acids Res. 41, 5149-5163 (2013).
31. Affaitati, A., de Cristofaro, T., Feliciello, A. & Varrone, S. Identifcation of alternative splicing of spinocerebellar ataxia type 2 gene. Gene 267, 89-93 (2001).
32. Yen, S.H., Hutton, M., DeTure, M., Ko, L.W. & Nacharaju, P. Fibrillogenesis of tau: insights from tau missense mutations in FTDP-17. Brain Pathol. 9, 695-705 (1999).
33. Kremerskothen, J. et al. Brain-specifc splicing of α-actinin 1 (ACTN1) mRNA. Biochem. Biophys. Res. Commun. 295, 678-681 (2002).
34. Tuncel, H. et al. PARP6, a mono(ADP-ribosyl) transferase and a negative regulator of cell proliferation, is involved in colorectal cancer development. Int. J. Oncol. 41, 2079-2086 (2012).
35. Gothié, E., Richard, D.E., Berra, E., Pages, G. & Pouyssegur, J. Identifcation of alternative spliced variants of human hypoxia-inducible factor-1α. J. Biol. Chem. 275, 6922-6927 (2000).
36. Ray, D. et al. A compendium of RNA-binding motifs for decoding gene regulation. Nature 499, 172-177 (2013).
37. Johnson, J.O. et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 17, 664-666 (2014).
38. Xia, Z. et al. Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′-UTR landscape across seven tumour types. Nat. Commun. 5, 5274 (2014).
39. van Blitterswijk, M. et al. Ataxin-2 as potential disease modifer in C9ORF72 expansion carriers. Neurobiol. Aging 35, 2421.e13-2421.e17 (2014).
40. Mori, K. et al. hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations. Acta Neuropathol. 125, 413-423 (2013).
41. Shi, Y. Alternative polyadenylation: new insights from global analyses. RNA 18, 2105-2117 (2012).
42. Batra, R. et al. Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease. Mol. Cell 56, 311-322 (2014).
43. Jenal, M. et al. The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites. Cell 149, 538-553 (2012).
44. Thivard, L. et al. Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability. J. Neurol. Neurosurg. Psychiatry 78, 889-892 (2007).
45. Seeley, W.W. et al. Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch. Neurol. 65, 249-255 (2008).
46. Tan, R.H. et al. Cerebellar integrity in the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One 9, e105632 (2014).
47. Bede, P. et al. Patterns of cerebral and cerebellar white matter degeneration in ALS. J. Neurol. Neurosurg. Psychiatry 86, 468-470 (2015).
48. Irwin, D.J. et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 84, 163-169 (2013).
49. Mahoney, C.J. et al. Longitudinal neuroimaging and neuropsychological profles of frontotemporal dementia with C9ORF72 expansions. Alzheimers Res. Ther. 4, 41 (2012).
50. Boeve, B.F. et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135, 765-783 (2012).
51. Brooks, B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J. Neurol. Sci. 124, 96-107 (1994).
52. Brooks, B.R., Miller, R.G., Swash, M. & Munsat, T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1, 293-299 (2000).
53. Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259 (1991).
54. Murray, M.E. et al. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol. 122, 673-690 (2011).
55. Murray, M.E. et al. Neuropathologically defned subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 10, 785-796 (2011).
56. Zhang, Y.J. et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA 106, 7607-7612 (2009).
57. Kalari, K.R. et al. MAP-RSeq: Mayo Analysis Pipeline for RNA sequencing. BMC Bioinformatics 15, 224 (2014).
58. Charizanis, K. et al. Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron 75, 437-450 (2012).
59. Robinson, M.D., McCarthy, D.J. & Smyth, G.K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140 (2010).
60. Huang, D.W., Sherman, B.T. & Lempicki, R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009).
61. de Hoon, M.J., Imoto, S., Nolan, J. & Miyano, S. Open source clustering software. Bioinformatics 20, 1453-1454 (2004).
62. Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).
63. Cline, M.S. et al. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2, 2366-2382 (2007).
64. Emig, D. et al. AltAnalyze and DomainGraph: analyzing and visualizing exon expression data. Nucleic Acids Res. 38, W755-W762 (2010).
65. Franceschini, A. et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808-D815 (2013).
66. Machanick, P. & Bailey, T.L. MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics 27, 1696-1697 (2011).
67. Huelga, S.C. et al. Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins. Cell Rep. 1, 167-178 (2012).
68. Masamha, C.P. et al. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature 510, 412-416 (2014).